Jeff Bluestone, Ph.d.
Scientific Advisor
immunology
Immun System
Luxembourg
Biography
Jeff Bluestone, Ph.D., is a scientific advisor to Vir. He also serves as president & CEO of the Parker Institute for Cancer Immunotherapy and is the A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology in the University of California San Francisco (UCSF) School of Medicine. Dr. Bluestone joined UCSF in 2000 as Director of the Diabetes Center and the NIH-sponsored Immune Tolerance Network. In March 2010, Dr. Bluestone was appointed executive vice chancellor and provost at UCSF serving as chief academic officer guiding the research and academic enterprise advancing the campus priorities in close collaboration with the chancellor and the campus leadership teams, and to oversee the campus ethics and compliance enterprise. His is currently the director of the Hormone Research Institute in the Diabetes Center and continues to conduct research focused on understanding the basic processes that control T-cell activation and immune tolerance in autoimmunity, cancer and organ transplantation.
Research Interest
Jeff Bluestone, Ph.D., is a scientific advisor to Vir. He also serves as president & CEO of the Parker Institute for Cancer Immunotherapy and is the A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology in the University of California San Francisco (UCSF) School of Medicine. Dr. Bluestone joined UCSF in 2000 as Director of the Diabetes Center and the NIH-sponsored Immune Tolerance Network. In March 2010, Dr. Bluestone was appointed executive vice chancellor and provost at UCSF serving as chief academic officer guiding the research and academic enterprise advancing the campus priorities in close collaboration with the chancellor and the campus leadership teams, and to oversee the campus ethics and compliance enterprise. His is currently the director of the Hormone Research Institute in the Diabetes Center and continues to conduct research focused on understanding the basic processes that control T-cell activation and immune tolerance in autoimmunity, cancer and organ transplantation.
